Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
Cisplatin (CDDP) remains a key drug for patients with advanced bladder cancer (BC), despite the emergence of new therapeutic agents; thus, the identification of factors contributing to CDDP treatment resistance is crucial. As acidity of the tumor microenvironment has been reported to be associated w...
Saved in:
| Main Authors: | Kaede Hiruma, Vladimir Bilim, Akira Kazama, Yuko Shirono, Masaki Murata, Yoshihiko Tomita |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/1/43 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of carfilzomib alone and in combination with cisplatin on the gene expression of Bcl-2 and Bax in ovarian carcinoma cell lines
by: Alireza Saedi, et al.
Published: (2025-03-01) -
Blockade of the STAT3/BCL-xL Axis Leads to the Cytotoxic and Cisplatin-Sensitizing Effects of Fucoxanthin, a Marine-Derived Carotenoid, on Human Bladder Urothelial Carcinoma Cells
by: Wen-Chyi Dai, et al.
Published: (2025-01-01) -
Xaf1诱导XIAP-/-成纤维细胞凋亡机制的研究
Published: (2008-01-01) -
Effectiveness of hesperidin and rutin on cisplatin-induced testicular dysfunction in rats
by: Dina M. I. Heibashy, et al.
Published: (2025-07-01) -
Late presentation of X-linked inhibitor of apoptosis (XIAP) deficiency in a young adult
by: Samina Nazarali, et al.
Published: (2025-04-01)